Literature DB >> 29253945

A novel structural fucosylated chondroitin sulfate from Holothuria Mexicana and its effects on growth factors binding and anticoagulation.

Qinying Li1, Chao Cai2, Yaoguang Chang3, Fuming Zhang4, Robert J Linhardt4, Changhu Xue5, Guoyun Li6, Guangli Yu7.   

Abstract

Fucosylated chondroitin sulfate (FCS), a structurally distinct glycosaminoglycan from the body wall of sea cucumber, possesses many biological properties and pharmacology functions. The refined structure of FCS isolated from sea cucumber Holothuria Mexicana (FCShm) was characterized by NMR spectra and HILIC-FTMS, which demonstrated four types of branches in FCShm. Among these, two branches were α-L-Fuc-2S4S (where Fuc is fucose and S is sulfo) and α-L-Fuc-4S linked to O-3 of glucuronic acid residues, while others were identified as α-L-Fuc-4S and α-L-Fuc-3S4S attached to O-6 of N-acetylgalactosamine residue. Furthermore, the fucosyl branches were α-1,3-linked with different degree of polymerization from 1 to 5. FCShm exhibited high affinity to fibroblast growth factor 1 and 2, growth factors involved in neovascularization. Moreover, FCShm displayed intrinsic anticoagulant activity and inhibited thrombin and factor Xa activation by antithrombin III. Our results proposed a novel structural FCS and demonstrated its favorable application prospects in anti-angiogenesis and anticoagulation.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Anti-angiogenesis; Anticoagulant; Fucosylated chondroitin sulfate; Holothuria mexicana; Structure elucidation

Mesh:

Substances:

Year:  2017        PMID: 29253945     DOI: 10.1016/j.carbpol.2017.10.100

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  10 in total

Review 1.  Chondroitin: a natural biomarker with immense biomedical applications.

Authors:  Dilipkumar Pal; Supriyo Saha
Journal:  RSC Adv       Date:  2019-09-06       Impact factor: 4.036

Review 2.  Marine Carbohydrate-Based Compounds with Medicinal Properties.

Authors:  Ariana A Vasconcelos; Vitor H Pomin
Journal:  Mar Drugs       Date:  2018-07-09       Impact factor: 5.118

Review 3.  (Semi)-Synthetic Fucosylated Chondroitin Sulfate Oligo- and Polysaccharides.

Authors:  Giulia Vessella; Serena Traboni; Antonio Laezza; Alfonso Iadonisi; Emiliano Bedini
Journal:  Mar Drugs       Date:  2020-06-01       Impact factor: 5.118

4.  A Study for the Access to a Semi-synthetic Regioisomer of Natural Fucosylated Chondroitin Sulfate with Fucosyl Branches on N-acetyl-Galactosamine Units.

Authors:  Giulia Vessella; Serena Traboni; Anna V A Pirozzi; Antonio Laezza; Alfonso Iadonisi; Chiara Schiraldi; Emiliano Bedini
Journal:  Mar Drugs       Date:  2019-11-21       Impact factor: 5.118

5.  Bottom-up analysis using liquid chromatography-Fourier transform mass spectrometry to characterize fucosylated chondroitin sulfates from sea cucumbers.

Authors:  Lufeng Yan; Lingyun Li; Junhui Li; Yanlei Yu; Xinyue Liu; Xingqian Ye; Robert J Linhardt; Shiguo Chen
Journal:  Glycobiology       Date:  2019-10-21       Impact factor: 4.313

Review 6.  Marine Antithrombotics.

Authors:  Rohini Dwivedi; Vitor H Pomin
Journal:  Mar Drugs       Date:  2020-10-13       Impact factor: 5.118

7.  Cancer Cell Inhibiting Sea Cucumber (Holothuria leucospilota) Protein as a Novel Anti-Cancer Drug.

Authors:  Ruizhen Ru; Yanzheng Guo; Juanxuan Mao; Zonghe Yu; Wen Huang; Xudong Cao; Huijian Hu; Minjie Meng; Lihong Yuan
Journal:  Nutrients       Date:  2022-02-13       Impact factor: 5.717

8.  rAj-Tspin, a novel recombinant peptide from Apostichopus japonicus, suppresses the proliferation, migration, and invasion of BEL-7402 cells via a mechanism associated with the ITGB1-FAK-AKT pathway.

Authors:  Ping Yu; Rui Wu; Zunchun Zhou; Xin Zhang; Ruoshu Wang; Xueting Wang; Sen Lin; Jihong Wang; Li Lv
Journal:  Invest New Drugs       Date:  2020-09-28       Impact factor: 3.651

9.  Fucosylated Chondroitin Sulfates from the Sea Cucumbers Paracaudina chilensis and Holothuria hilla: Structures and Anticoagulant Activity.

Authors:  Nadezhda E Ustyuzhanina; Maria I Bilan; Andrey S Dmitrenok; Alexandra S Silchenko; Boris B Grebnev; Valentin A Stonik; Nikolay E Nifantiev; Anatolii I Usov
Journal:  Mar Drugs       Date:  2020-10-28       Impact factor: 5.118

10.  Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy.

Authors:  Jia-Yang Wang; Ya-Qi Song; Jing Peng; Hong-Lei Luo
Journal:  ACS Omega       Date:  2020-09-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.